During the past decade, Illinois CancerCare-Ottawa Clinic conducted 206 clinical trials. In the 10-year time frame, 206 clinical trials started and 135 clinical trials were completed, i.e. on average, 65.5% percent of trials that started reached the finish line to date. In the past 5 years, 98 clinical trials started and 81 clinical trials were completed. i.e. 82.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Illinois CancerCare-Ottawa Clinic" #1 sponsor was "National Cancer Institute (NCI)" with 172 trials, followed by "SWOG Cancer Research Network" with 51 trials sponsored, "Alliance for Clinical Trials in Oncology" with 44 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 24 trials sponsored and "NRG Oncology" with 24 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois CancerCare-Ottawa Clinic" #1 collaborator was "National Cancer Institute (NCI)" with 150 trials as a collaborator, "NRG Oncology" with 30 trials as a collaborator, "Canadian Cancer Trials Group" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 6 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Illinois CancerCare-Ottawa Clinic" are "Recurrent Breast Carcinoma" (11 trials), "Stage IV Lung Cancer AJCC v8" (11 trials), "Invasive Breast Carcinoma" (10 trials), "Recurrent Ovarian Carcinoma" (10 trials) and "Recurrent Squamous Cell Lung Carcinoma" (10 trials). Many other conditions were trialed in "Illinois CancerCare-Ottawa Clinic" in a lesser frequency.

Most popular intervention types in "Illinois CancerCare-Ottawa Clinic" are "Drug" (263 trials), "Other" (205 trials), "Biological" (129 trials), "Procedure" (84 trials) and "Radiation" (49 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (103 trials), "Quality-of-Life Assessment" (85 trials), "Questionnaire Administration" (57 trials), "Computed Tomography" (42 trials) and "Cisplatin" (41 trials). Other intervention names were less common.

The vast majority of trials in "Illinois CancerCare-Ottawa Clinic" are 264 trials for "All" genders, 50 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Illinois CancerCare-Ottawa Clinic". undefined are not yet recruiting, 91 are recruiting, 134 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 73 completed trials in Illinois CancerCare-Ottawa Clinic, 9 suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Illinois CancerCare-Ottawa Clinic, 17 "Phase 1" clinical trials were conducted, 162 "Phase 2" clinical trials and 162 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".